Role of Aminoglycoside Antibiotics in the Treatment of Intra-abdominal Infection

Overview

Journal Antimicrob Agents Chemother

Publisher American Society for Microbiology

Specialty Pharmacology

Date 1987 Apr 1

PMID 3300527

Citations 13

Authors

J L Ho

M Barza

Affiliations

Soon will be listed here.

Citing Articles

The nephroprotective potential of selected synthetic compound against gentamicin induced nephrotoxicity.

Amir S, Abid M, Nadeem H, Tipu M, Irshad N BMC Pharmacol Toxicol. 2024; 25(1):68.

PMID: 39334457 PMC: 11438099. DOI: 10.1186/s40360-024-00765-3.

Protective effect of pomegranate flower extract against gentamicin-induced renal toxicity in male rats.

Sadeghi F, Nematbakhsh M, Noori-Diziche A, Eshraghi-Jazi F, Talebi A, Nasri H J Renal Inj Prev. 2015; 4(2):45-50.

PMID: 26060837 PMC: 4459728. DOI: 10.12861/jrip.2015.10.

Camel milk beneficial effects on treating gentamicin induced alterations in rats.

Al-Asmari A, Abbasmanthiri R, Al-Elewi A, Al-Omani S, Al-Asmary S, Al-Asmari S J Toxicol. 2014; 2014:917608.

PMID: 25544839 PMC: 4269313. DOI: 10.1155/2014/917608.

Spirulina platensis protects against renal injury in rats with gentamicin-induced acute tubular necrosis.

Avdagic N, Cosovic E, Nakas-Icindic E, Mornjakovic Z, Zaciragic A, Hadzovic-Dzuvo A Bosn J Basic Med Sci. 2009; 8(4):331-6.

PMID: 19125703 PMC: 5677276. DOI: 10.17305/bjbms.2008.2892.

Renoprotective effect of erdosteine in rats against gentamicin nephrotoxicity: a comparison of 99mTc-DMSA uptake with biochemical studies.

Cabuk M, Gurel A, Sen F, Demircan N Mol Cell Biochem. 2007; 308(1-2):35-42.

PMID: 17899318 DOI: 10.1007/s11010-007-9609-0.

References

Drusano G, WARREN J, Saah A, Caplan E, Tenney J, Hansen S . A prospective randomized controlled trial of cefoxitin versus clindamycin-aminoglycoside in mixed anaerobic-aerobic infections. Surg Gynecol Obstet. 1982; 154(5):715-20. View

Tally F, KELLUM J, Ho J, ODonnell T, Barza M, Gorbach S . Randomized prospective study comparing moxalactam and cefoxitin with or without tobramycin for the treatment of serious surgical infections. Antimicrob Agents Chemother. 1986; 29(2):244-9. PMC: 176385. DOI: 10.1128/AAC.29.2.244. View

Van der Auwera P, Collier J, Goris R, Saario I, Willis A . A comparison of metronidazole and clindamycin for the treatment of intra-abdominal anaerobic infection: a multicentre trial. J Antimicrob Chemother. 1982; 10(1):57-66. DOI: 10.1093/jac/10.1.57. View

David I, Buck J, FILLER R . Rational use of antibiotics for perforated appendicitis in childhood. J Pediatr Surg. 1982; 17(5):494-500. DOI: 10.1016/s0022-3468(82)80096-1. View

Schentag J, WELS P, Reitberg D, Walczak P, Van Tyle J, Lascola R . A randomized clinical trial of moxalactam alone versus tobramycin plus clindamycin in abdominal sepsis. Ann Surg. 1983; 198(1):35-41. PMC: 1352928. DOI: 10.1097/00000658-198307000-00007. View

Young M, Bresnitz E, Strom B . Sample size nomograms for interpreting negative clinical studies. Ann Intern Med. 1983; 99(2):248-51. DOI: 10.7326/0003-4819-99-2-248. View

Gutmann L, Williamson R . A model system to demonstrate that beta-lactamase-associated antibiotic trapping could be a potential means of resistance. J Infect Dis. 1983; 148(2):316-21. DOI: 10.1093/infdis/148.2.316. View

Heseltine P, Yellin A, APPLEMAN M, Gill M, Chenella F, Kern J . Perforated and gangrenous appendicitis: an analysis of antibiotic failures. J Infect Dis. 1983; 148(2):322-9. DOI: 10.1093/infdis/148.2.322. View

Saario I, Arvilommi H, SILVOLA H . Comparison of cefuroxime and gentamicin in combination with metronidazole in the treatment of peritonitis due to perforation of the appendix. Acta Chir Scand. 1983; 149(4):423-6. View

10.

McLaughlin F, Matthews Jr W, Strieder D, Sullivan B, Goldmann D . Randomized, double-blind evaluation of azlocillin for the treatment of pulmonary exacerbations of cystic fibrosis. J Antimicrob Chemother. 1983; 11 Suppl B:195-203. DOI: 10.1093/jac/11.suppl_b.195. View

11.

Sanders C, Sanders Jr W . Emergence of resistance during therapy with the newer beta-lactam antibiotics: role of inducible beta-lactamases and implications for the future. Rev Infect Dis. 1983; 5(4):639-48. DOI: 10.1093/clinids/5.4.639. View

12.

Foster T . Plasmid-determined resistance to antimicrobial drugs and toxic metal ions in bacteria. Microbiol Rev. 1983; 47(3):361-409. PMC: 281581. DOI: 10.1128/mr.47.3.361-409.1983. View

13.

Najem A, KAMINSKI Z, Spillert C, LAZARO E . Comparative study of parenteral piperacillin and cefoxitin in the treatment of surgical infections of the abdomen. Surg Gynecol Obstet. 1983; 157(5):423-5. View

14.

Scully B, Neu H . Clinical efficacy of ceftazidime. Treatment of serious infection due to multiresistant Pseudomonas and other gram-negative bacteria. Arch Intern Med. 1984; 144(1):57-62. DOI: 10.1001/archinte.144.1.57. View

15.

King D, BROWNE A, Birken G, Hilty M, Kerzner B, BOLES Jr E . Antibiotic management of complicated appendicitis. J Pediatr Surg. 1983; 18(6):945-50. DOI: 10.1016/s0022-3468(83)80051-7. View

16.

Kahlmeter G, Dahlager J . Aminoglycoside toxicity - a review of clinical studies published between 1975 and 1982. J Antimicrob Chemother. 1984; 13 Suppl A:9-22. DOI: 10.1093/jac/13.suppl_a.9. View

17.

Nichols R, Smith J, Klein D, Trunkey D, Cooper R, Adinolfi M . Risk of infection after penetrating abdominal trauma. N Engl J Med. 1984; 311(17):1065-70. DOI: 10.1056/NEJM198410253111701. View

18.

Henning C, Frolander F, Karlsson J, Dornbusch K . Comparative study of netilmicin/tinidazole versus netilmicin/clindamycin in the treatment of severe abdominal infections. Scand J Infect Dis. 1984; 16(3):297-303. DOI: 10.3109/00365548409070404. View

19.

MacGregor R, Gentry L . Imipenem/cilastatin in the treatment of osteomyelitis. Am J Med. 1985; 78(6A):100-3. DOI: 10.1016/0002-9343(85)90109-3. View

20.

Salata R, Gebhart R, PALMER D, Wade B, Scheld W, Groschel D . Pneumonia treated with imipenem/cilastatin. Am J Med. 1985; 78(6A):104-9. DOI: 10.1016/0002-9343(85)90110-x. View